Seqirus says it can supply 60 mln doses of influenza vaccines for U.S. flu season
July 27 (Reuters) - Vaccine maker Seqirus, a part of Australia-based biotech company CSL Ltd, said on Tuesday it has started shipping its influenza...
July 27 (Reuters) - Vaccine maker Seqirus, a part of Australia-based biotech company CSL Ltd, said on Tuesday it has started shipping its influenza...